Starling Oncology (STLN)'s 30-day implied volatility (IV30) was 71.5% at the close on October 20, 2026, down from 76.9% the day before, against a 52-week range of 40.0% to 400.0%. Its 20-day historical volatility was 58.5%.
Data as of October 20, 2026.